Laguna Niguel-based Inspiration Biopharmaceuticals, a developer of treatments for hemophilia, announced today that it has appointed John P. Butler as its new CEO. Butler replaces current CEO Michael Griffith, who becomes Chief Scientific Officer and President. Butler was most recently at Genzyme Corporation, and has served at Amgen and Hoffmann-La Roche.